This research offers valuable insights into optimizing the structure of platinum-based catalysts to enhance their catalytic activity and stability. The ultra-low platinum loading ORR electrocatalyst developed in this study has the potential to significantly reduce the cost of fuel cells and zinc-air batteries, making them more viable for commercial applications. The findings pave the way for the development of more efficient and cost-effective energy conversion devices.

Brain-computer interface (BCI) technology is opening an unprecedented chapter in human-machine integration by establishing direct communication between the brain and external devices.

The color and texture of pear skin greatly influence its market value and consumer appeal. 

The advancement of artificial intelligence (AI) has ushered in a new era of automated robotics that are adaptive to their environments.   The field of robotics has made remarkable strides over the past few decades, yet it continues to face challenges that hinder the full utilisation of its potential. Traditional robots often rely on pre-programmed instructions and restricted configurations, limiting their ability to respond to unforeseen circumstances. AI technologies - encompassing cognition, analysis, inference, and decision-making-enable robots to operate intelligently, significantly enhancing their capabilities to assist and support humans. 

Plant genome editing through CRISPR-Cas holds transformative potential, yet its precision remains hampered by low gene targeting (GT) efficiency. 

Bananas are a staple for millions, yet their production is threatened by limited genetic diversity and breeding challenges.

Understanding how grapevines respond to drought is key to future-proofing viticulture in a changing climate.

Potatoes don't sprout by accident—timing is everything. A newly identified microRNA, named stu-miR319c, has been found to play a pivotal role in telling potato tubers when to break dormancy and start growing. 

In a recent study, researchers have uncovered the biological trigger behind the dangerous immune-related adverse events (irAEs) that occur when the epidermal growth factor receptor (EGFR) inhibitor osimertinib is combined with immune checkpoint inhibitors (ICIs).